New, long-term results from a clinical trial show that MAGE-A3 ASCI, an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery -- to the same extent as chemotherapy but without the side-effects of chemotherapy.
Cancer Immunotherapy Reduces Risk Of Relapse After Surgery, Stud...Courtesy ScienceDaily Thu, 04/24/2008 - 23:00
New, long-term results from a clinical trial show that MAGE-A3 ASCI, an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery -- to the same extent as chemotherapy but without the side-effects of chemotherapy. More related itemsGene Panel Predicts Lung Cancer Survival, Study Finds
Why Only Some Former Smokers Develop Lung Cancer
Broccoli May Lower Lung Cancer Risk In Smokers
Soapmaker's Companion: A Comprehensive Guide with...
The Black Hole War: My Battle with Stephen Hawking to...
|
Popular by tags Week |
Post new comment